When gratitude becomes strategy: Did the hospital go too far?
A doctor friend recently forwarded a memo from his hospital’s development office. It praised “grateful patient philanthropy,” urged clinicians to identify people who “might be open to a conversation,” invited them to introduce a development officer during rounds, and suggested adding a sentence about giving to their discharge discussions. There were benchmarks, too: clinicians who “successfully partner with philanthropy” would be recognized at year’s end.
He was uneasy. Was management simply asking for help to keep the lights on—or conscripting physicians into fundraising in ways that risked patients’ trust?
Why hospitals are leaning on clinicians
Philanthropy has become a strategic pillar for many hospitals. Margins are thin, capital projects are expensive, Medicare and Medicaid often pay below cost, and cross-subsidies from commercial insurance are under pressure. Donations can fund research, equipment, free clinics, and social services that otherwise wouldn’t happen.
The most effective gifts often come from people who have personally experienced the hospital’s care. Development teams call this “grateful patient” fundraising. The logic is straightforward: clinicians are the face of that experience. If physicians introduce the idea at the right time, a grateful family might fund a fellowship or a new NICU.
But what’s compelling from a revenue standpoint can be troubling from a clinical and ethical one.
What the law allows—and what trust requires
U.S. privacy law gives development offices some room to work. Under HIPAA, hospitals can use limited information to contact patients for fundraising—basic demographics, dates of service, the department where you received care, the name of your treating clinician, and broad outcome information—so long as patients are told they can opt out of such communications. Using diagnoses, clinical details, or sharing stories requires explicit patient authorization.
Those rules set the floor, not the ceiling. Patients often don’t expect their caregiver to pivot into a fundraising role, and subtle pressure can feel like coercion in a vulnerable moment. Ethical codes emphasize that the physician’s primary obligation is to the patient’s welfare, without conflicts that could color judgment or erode trust.
Where hospitals cross the line
Not every fundraising tactic is created equal. Some are compatible with patient-centered care; others are not. Here are common practices and how they stack up.
Generally acceptable with safeguards
– Sending fundraising letters that note the department or treating physician, with a clear, easy opt-out.
– Inviting clinicians to share public updates about research or programs, without singling out patients.
– Training development staff to wait until after an episode of care is complete before any outreach, and to withdraw at the first sign of discomfort.
– Allowing clinicians to participate voluntarily—for example, recording a thank-you video or speaking at a donor event—without pressure or incentives tied to giving.
Ethically risky or clearly over the line
– “Bedside asks” by clinicians or development officers during active treatment. Vulnerability and perceived dependency make genuine consent doubtful.
– Tracking or rewarding clinicians based on dollars raised, referrals to development, or “number of prospects identified.” That creates a conflict with clinical loyalty.
– Instructing physicians to suggest giving during discharge planning or to combine care updates with a philanthropic pitch.
– Wealth screening of current patient lists without clear, up-front notice and an easy opt-out. Even if legal under certain interpretations, it feels like surveillance to many patients.
– Providing faster appointments, special clinical access, or “VIP wings” that materially advantage donors over clinically similar non-donors. Amenities are one thing; preferential triage is another.
– Allowing donors to influence clinical decisions, study design, or the care of named patients. Funding priorities can be shaped by philanthropy; individual care should not be.
– Commingling fundraising with quality metrics or performance reviews for clinicians. The two must be firewalled.
Red flags in your friend’s memo
My friend’s memo included at least three red flags:
– Asking clinicians to identify “open” patients and introduce development officers during rounds. Even a warm handoff can feel like pressure at the bedside. Timing and setting matter.
– Suggesting clinicians add a giving prompt to discharge discussions. Discharge is about safety, medications, and follow-up, not philanthropy.
– “Recognition” for clinicians who “partner successfully.” If recognition becomes expectation, or if compensation or promotions are tied—explicitly or tacitly—to fundraising, trust is at risk.
None of these are necessary to run a robust philanthropy program. All of them shift the physician’s role from advocate to agent of the institution’s financial interests at a moment when patients are dependent and impressionable.
What a better approach looks like
Hospitals can raise serious money without compromising clinical integrity. The core is separation of roles, transparency, and patient control.
For leaders
– Make clinician participation truly voluntary. No quotas, scorecards, or compensation tied to dollars raised. Put that in writing.
– Keep solicitations out of the clinical encounter. No bedside asks. If development officers visit care areas, it should be for staff education, not patient approaches.
– Get consent right. Prominently disclose fundraising uses of limited information at registration, offer a simple opt-out, and honor it across the enterprise. Require explicit authorization for any story, photo, or clinical detail.
– Use humane timing and channels. Send a letter or email weeks after discharge, from the development office—not the clinician—explaining how giving helps and how to decline future appeals.
– Separate access from influence. Offer donor amenities that don’t change clinical priority. Enforce policies that triage solely by medical need. Audit for drift.
– Govern and audit. Put fundraising policies through ethics, compliance, and privacy review; train both clinicians and development staff; audit adherence annually; include patient advisors in oversight.
– Be transparent about wealth screening. If used, disclose it plainly, contract with vendors as business associates with strict data limits, and allow patients to opt out of screening as well as solicitations.
– Mind equity. Set philanthropic goals that also fund safety-net services and community health, not only marquee buildings.
For clinicians
– Ask for the policy. Clarify what information development uses, how opt-outs work, and what’s expected of you. Decline roles that blur care with solicitation.
– Set boundaries. It’s appropriate to thank patients for kindness and direct them, if they ask about giving, to the development office after their care episode, without joining the ask.
– Keep care conversations about care. Do not add fundraising language to discharge instructions, informed consent, or prognosis discussions.
– Avoid introducing development at the bedside. If you choose to engage, do it outside clinical encounters and only when the patient or family initiates interest.
– Protect confidentiality. Never share diagnoses, stories, or photos without explicit written authorization specific to that use.
– Seek backup. If you feel pressured, bring concerns to your department chair, privacy officer, or ethics committee. Many leaders will correct overreach once it’s surfaced.
Answering the question: Did management go too far?
Based on the memo’s tactics—physician-facilitated introductions during rounds, fundraising scripts woven into discharge, and recognition tied to clinician “partnership”—yes, they likely did. Even if legal risk is managed, the ethical risk is not. Patients need to know that every word from their clinician is aimed at their health interests alone. Anything that muddles that signal endangers the trust on which care depends.
There is a workable middle ground. Hospitals can tell compelling stories, steward grateful families, and build transformational programs without recruiting clinicians into the ask or turning the bedside into a development venue. They can be candid with patients about data use, make opting out easy, and bind themselves to a simple promise: philanthropy will never influence your care or your clinician’s judgment.
Your friend’s discomfort is not only reasonable; it is a professional compass pointing north. Administrators should welcome that signal. If philanthropy undermines trust, it undercuts the very reason many donors give in the first place.
